Having demonstrated that the loss of CLDN3 expression in the mouse gut promotes gut dysbiosis and that these mice have an increased susceptibility to colitis, we further examined the relevance of CLDN3 expression in IBD and associated microbiome changes. Here, CLDN3 is linked to colitis.